Preclinical Long-Term Stability and Forced Degradation Assessment of EPICERTIN, a Mucosal Healing Biotherapeutic for Inflammatory Bowel Disease

Preclinical Long-Term Stability and Forced Degradation Assessment of EPICERTIN, a Mucosal Healing Biotherapeutic for Inflammatory Bowel Disease

<b>Background/Objectives:</b> EPICERTIN, a biotherapeutic candidate for mucosal healing in inflammatory bowel disease (IBD) and other mucosal disorders, was subjected to an extensive long-term stability program to evaluate its molecular stability and physicochemical properties. Additiona...

Full description

Saved in:
Bibliographic Details
Main Authors: Wendy M. Kittle, Micaela A. Reeves, Ashley E. Fulkerson, Krystal T. Hamorsky, David A. Morris, Kathleen T. Kitterman, Michael L. Merchant, Nobuyuki Matoba
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Pharmaceutics
Subjects:
cholera toxin B subunit
EPICERTIN
long-term stability
forced degradation
drug development
biopharmaceuticals
Online Access:https://www.mdpi.com/1999-4923/17/2/259
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1999-4923/17/2/259

Similar Items